Valeant Eyeing Dermatology, Dentistry for M&A: CEO

Valeant Eyeing Dermatology, Dentistry for M&A: CEO Play

March 19 (Bloomberg) -- Mike Pearson, chief executive officer of Valeant Pharmaceuticals International Inc., talks about the company's acquisition and growth strategy. He speaks with Stephanie Ruhle and Matt Miller on Bloomberg Television's "Market Makers." (Source: Bloomberg)

blog comments powered by Disqus